Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BRUKER CORPBRKR · Entity 3609 | Director | June 14, 2017 | June 15, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BRUKER CORP
Report date June 14, 2017 · Filed June 15, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,577 |
Ending reported balance
After 2017-06-14 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2017-06-14 · Exercise / conversion · Acquired 10,000 · Balance 14,577 Row 2 · 2017-06-14 · Exercise / conversion · Acquired 6,600 · Balance 21,177 Row 3 · 2017-06-14 · Exercise / conversion · Acquired 3,300 · Balance 24,477 Row 4 · 2017-06-14 · Sale · Disposed 19,900 · Balance 4,577 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.91 to $28.26, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.07 · Expires 2024-01-06 | Direct | 0 |
Reported balance
After 2017-06-14 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-06-14 · Exercise / conversion · Disposed 10,000 · Balance 0 F2: The options exercised vested in three approximately equal annual installments on the anniversary of the grant date commencing January 6, 2015. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.12 · Expires 2025-01-05 | Direct | 3,400 |
Reported balance
After 2017-06-14 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2017-06-14 · Exercise / conversion · Disposed 6,600 · Balance 3,400 F3: The options exercised vested in two approximately equal annual installments on January 5, 2016 and 2017. The remaining will vest on January 5, 2018. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $24.00 · Expires 2026-01-05 | Direct | 6,700 |
Reported balance
After 2017-06-14 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-06-14 · Exercise / conversion · Disposed 3,300 · Balance 6,700 F4: The options exercised vested on January 5, 2017. The remaining options will vest in two approximately equal annual installments on each of January 5, 2018 and 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.91 to $28.26, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The options exercised vested in three approximately equal annual installments on the anniversary of the grant date commencing January 6, 2015.
F3: The options exercised vested in two approximately equal annual installments on January 5, 2016 and 2017. The remaining will vest on January 5, 2018.
F4: The options exercised vested on January 5, 2017. The remaining options will vest in two approximately equal annual installments on each of January 5, 2018 and 2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 14, 2017 Filed Jun 15, 2017 14:07 UTC | BRUKER CORP BRKR · Entity 3609 | Exercise / conversionStock Option (right to buy) · Derivative | 3,300 | $0.00 Strike: $24.00 | $0.00 |
DisclosureSEC source: 0001179110-17-009096 · edgar.xml · derivative · entry 7 VAN INGEN CHRIS · CIK 0001142621 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,700 Underlying: Common Stock · 3,300 shares Expires 2026-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options exercised vested on January 5, 2017. The remaining options will vest in two approximately equal annual installments on each of January 5, 2018 and 2019. Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 14:07 UTC | BRUKER CORP BRKR · Entity 3609 | Exercise / conversionStock Option (right to buy) · Derivative | 6,600 | $0.00 Strike: $19.12 | $0.00 |
DisclosureSEC source: 0001179110-17-009096 · edgar.xml · derivative · entry 6 VAN INGEN CHRIS · CIK 0001142621 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,400 Underlying: Common Stock · 6,600 shares Expires 2025-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options exercised vested in two approximately equal annual installments on January 5, 2016 and 2017. The remaining will vest on January 5, 2018. Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 14:07 UTC | BRUKER CORP BRKR · Entity 3609 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $19.07 | $0.00 |
DisclosureSEC source: 0001179110-17-009096 · edgar.xml · derivative · entry 5 VAN INGEN CHRIS · CIK 0001142621 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2024-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options exercised vested in three approximately equal annual installments on the anniversary of the grant date commencing January 6, 2015. Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 14:07 UTC | BRUKER CORP BRKR · Entity 3609 | SaleCommon Stock | 19,900 | $28.03 | $557,888.54 |
DisclosureSEC source: 0001179110-17-009096 · edgar.xml · nonDerivative · entry 4 VAN INGEN CHRIS · CIK 0001142621 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,577 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.91 to $28.26, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 14:07 UTC | BRUKER CORP BRKR · Entity 3609 | Exercise / conversionCommon Stock | 3,300 | $24.00 | $79,200.00 |
DisclosureSEC source: 0001179110-17-009096 · edgar.xml · nonDerivative · entry 3 VAN INGEN CHRIS · CIK 0001142621 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,477 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 14:07 UTC | BRUKER CORP BRKR · Entity 3609 | Exercise / conversionCommon Stock | 6,600 | $19.12 | $126,192.00 |
DisclosureSEC source: 0001179110-17-009096 · edgar.xml · nonDerivative · entry 2 VAN INGEN CHRIS · CIK 0001142621 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,177 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 14:07 UTC | BRUKER CORP BRKR · Entity 3609 | Exercise / conversionCommon Stock | 10,000 | $19.07 | $190,700.00 |
DisclosureSEC source: 0001179110-17-009096 · edgar.xml · nonDerivative · entry 1 VAN INGEN CHRIS · CIK 0001142621 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,577 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2017 Filed Jan 9, 2017 21:02 UTC | BRUKER CORP BRKR · Entity 3609 | GrantCommon Stock | 4,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-000753 · edgar.xml · nonDerivative · entry 1 VAN INGEN CHRIS · CIK 0001142621 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,577 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in one installment on January 5, 2018. Read SEC document |
| December 13, 2016 Filed Dec 14, 2016 21:11 UTC | BRUKER CORP BRKR · Entity 3609 | Exercise / conversionStock Option (Right to buy) · Derivative | 10,000 | $0.00 Strike: $16.42 | $0.00 |
DisclosureSEC source: 0001179110-16-032944 · edgar.xml · derivative · entry 7 VAN INGEN CHRIS · CIK 0001142621 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2023-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options vested in approximately equal annual installments on January 7, 2014, 2015 and 2016. Read SEC document |
| December 13, 2016 Filed Dec 14, 2016 21:11 UTC | BRUKER CORP BRKR · Entity 3609 | Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $12.06 | $0.00 |
DisclosureSEC source: 0001179110-16-032944 · edgar.xml · derivative · entry 6 VAN INGEN CHRIS · CIK 0001142621 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2022-08-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vested in approximately equal annual installments on August 13, 2013, 2014 and 2015. Read SEC document |
| December 13, 2016 Filed Dec 14, 2016 21:11 UTC | BRUKER CORP BRKR · Entity 3609 | Exercise / conversionStock Option (Right to buy) · Derivative | 5,000 | $0.00 Strike: $12.96 | $0.00 |
DisclosureSEC source: 0001179110-16-032944 · edgar.xml · derivative · entry 5 VAN INGEN CHRIS · CIK 0001142621 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2022-06-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options vested in approximately equal annual installments on June 25, 2013, 2014 and 2015. Read SEC document |
| December 13, 2016 Filed Dec 14, 2016 21:11 UTC | BRUKER CORP BRKR · Entity 3609 | SaleCommon stock | 20,000 | $22.29 | $445,836.00 |
DisclosureSEC source: 0001179110-16-032944 · edgar.xml · nonDerivative · entry 4 VAN INGEN CHRIS · CIK 0001142621 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.131 to $22.60, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) of this Form 4. Read SEC document |
| December 13, 2016 Filed Dec 14, 2016 21:11 UTC | BRUKER CORP BRKR · Entity 3609 | Exercise / conversionCommon Stock | 10,000 | $16.42 | $164,200.00 |
DisclosureSEC source: 0001179110-16-032944 · edgar.xml · nonDerivative · entry 3 VAN INGEN CHRIS · CIK 0001142621 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2016 Filed Dec 14, 2016 21:11 UTC | BRUKER CORP BRKR · Entity 3609 | Exercise / conversionCommon Stock | 5,000 | $12.06 | $60,300.00 |
DisclosureSEC source: 0001179110-16-032944 · edgar.xml · nonDerivative · entry 2 VAN INGEN CHRIS · CIK 0001142621 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2016 Filed Dec 14, 2016 21:11 UTC | BRUKER CORP BRKR · Entity 3609 | Exercise / conversionCommon Stock | 5,000 | $12.96 | $64,800.00 |
DisclosureSEC source: 0001179110-16-032944 · edgar.xml · nonDerivative · entry 1 VAN INGEN CHRIS · CIK 0001142621 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.